Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

Current Treatment Options in Oncology especially in healthcare systems with limited
resources, is crucial to prevent widening healthcare disparities. In conclusion, targeted …

Pituitary tumors (PT) account for 15% of intracranial tumors affect 10.7%–14.4% of the
population although the incidence of clinically relevant PT is 5.1 cases/100,000 inhabitants …

Purpose: The goal of this study was to develop end-to-end convolutional neural network
(CNN) models that can noninvasively discriminate papillary craniopharyngioma (PCP) from …

Craniopharyngioma (CP) is a rare intracranial tumor arising from the epithelial remnants of
Rathke's pouch, most frequently originating in the sellar/parasellar region. Histologically, CP …

Background The management of craniopharyngiomas is challenging due to their high rate of
recurrence following resection. Excision of recurrent tumors poses further surgical …

Abstract In 2021, the World Health Organization released the fifth edition of the central
nervous system (CNS) tumor classification. This classification uses histopathology and …

Introduction Optimal planning and minimally invasive surgical approach are essential to
complete craniopharyngiomas (CP) resection with limited postoperative morbidity. Given the …

Introduction Hypothalamic invasion in pediatric patients with craniopharyngioma negatively
influences clinical outcomes. It has been shown that radiologic classification of hypothalamic …

Los tumores hipofisarios (TH) suponen el 15% de los tumores intracraneales, y afectan del
10, 7 al 14, 4% de la población, si bien la incidencia de los TH clínicamente relevantes es …